Cite
HARVARD Citation
Marchesi, F. et al. (2014). Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single‐institution study. Transplant infectious disease. 16 (6), pp. 1032-1038. [Online].